Show simple item record

dc.contributor.authorGabillard, Delphine*
dc.contributor.authorLewden, Charlotte*
dc.contributor.authorNdoye, Ibra*
dc.contributor.authorMoh, Raoul*
dc.contributor.authorSegeral, Olivier*
dc.contributor.authorTonwe-Gold, Besigin*
dc.contributor.authorEtard, Jean-François*
dc.contributor.authorPagnaroat, Men*
dc.contributor.authorFournier-Nicolle, Isabelle*
dc.contributor.authorEholié, Serge*
dc.contributor.authorKonate, Issouf*
dc.contributor.authorMinga, Albert*
dc.contributor.authorMpoudi-Ngole, Eitel*
dc.contributor.authorKoulla-Shiro, Sinata*
dc.contributor.authorZannou, Djimon Marcel*
dc.contributor.authorAnglaret, Xavier*
dc.contributor.authorLaurent, Christian*
dc.date.accessioned2014-11-30T16:11:39Z
dc.date.available2014-11-30T16:11:39Z
dc.date.issued2013-04-15
dc.identifier.citationMortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. 2013, 62 (5):555-61 J. Acquir. Immune Defic. Syndr.en_GB
dc.identifier.issn1944-7884
dc.identifier.pmid23274931
dc.identifier.doi10.1097/QAI.0b013e3182821821
dc.identifier.urihttp://hdl.handle.net/10144/336359
dc.description.abstractIn resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.
dc.language.isoenen
dc.publisherLippincott Williams and Wilkinsen_GB
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en_GB
dc.subjectHIV/AIDSen_GB
dc.subject.meshAcquired Immunodeficiency Syndromeen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.meshAfrica South of the Saharaen_GB
dc.subject.meshAnti-HIV Agentsen_GB
dc.subject.meshAsiaen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHIV-1en_GB
dc.subject.meshHumansen_GB
dc.subject.meshIncidenceen_GB
dc.subject.meshLinear Modelsen_GB
dc.subject.meshMaleen_GB
dc.subject.meshYoung Adulten_GB
dc.titleMortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en_GB
refterms.dateFOA2019-03-04T11:36:54Z
html.description.abstractIn resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.


Files in this item

Thumbnail
Name:
Gabillard et al-2013-Mortality ...
Size:
404.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record